Publications by authors named "Toru Uchimura"

Claim this Profile
L
Long-term outcome of mycophenolate mofetil after a single dose of rituximab in childhood-onset refractory idiopathic nephrotic syndrome.
Taishi Nada, Koichi Kamei, Kentaro Nishi, Toru Uchimura, Aya Inaba

Clin Exp Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two adolescents with frequently relapsing nephrotic syndrome newly diagnosed after SARS-CoV-2 vaccination: case report and literature review.
Eriko Nakazawa, Toru Uchimura, Rie Ohyama, Hayato Togashi, Aya Inaba

CEN Case Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recovery from rituximab-associated persistent hypogammaglobulinaemia in children with nephrotic syndrome.
Daishi Hirano, Takuya Fujimaru, Mayumi Sako, Seiji Tanaka, Aya Inaba, Toru Uchimura

Nephrol Dial Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multinucleated podocytes as a clue to diagnosis of juvenile nephropathic cystinosis.
Ayako Ogata, Saori Deki, Toru Uchimura, Aya Inaba, Masako Otani

Pediatr Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early predictive factors for progression to kidney failure in infants with severe congenital anomalies of the kidney and urinary tract.
Kentaro Nishi, Osamu Uemura, Ryoko Harada, Masaki Yamamoto, Yusuke Okuda, Toru Uchimura

Pediatr Nephrol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive immunotherapy combined with bortezomib and rituximab for membranous nephropathy associated with enzyme replacement therapy in Pompe disease.
Keigo Sasaki, Toru Uchimura, Aya Inaba, Masako Otani, Junko Hanakawa

Pediatr Nephrol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
Eriko Nakazawa, Toru Uchimura, Yuji Hirai, Hayato Togashi, Yoshitaka Oyama

CEN Case Rep· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
Brandon M Johnson, Toru Uchimura, Matthew D Gallovic, Madhan Thamilarasan, Wei-Chun Chou

J Immunol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity Expands a Distinct Population of T Cells in Adipose Tissue and Increases Vulnerability to Infection.
Ichiro Misumi, Joshua Starmer, Toru Uchimura, Melinda A Beck, Terry Magnuson

Cell Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Locus in Mice that Regulates the Collateral Damage and Lethality of Virus Infection.
Ichiro Misumi, Kevin D Cook, Joseph E Mitchell, Makayla M Lund, Sarah C Vick, Toru Uchimura

Cell Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Innate Immune Sensor NLRC3 Acts as a Rheostat that Fine-Tunes T Cell Responses in Infection and Autoimmunity.
Toru Uchimura, Yoshitaka Oyama, Meng Deng, Haitao Guo, Justin E Wilson

Immunity· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan.
Toru Uchimura, Masaaki Mori, Akiyoshi Nariai, Shumpei Yokota

J Infect Chemother· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis